Inventor · disambiguated record
Michael P. Dwyer
Also filed as: DWYER MICHAEL · DWYER MICHAEL P
51 granted patents·17 pending applications·557 citations·filing 2002–2017
98Inventor score
Files withSCHERING CORP34MERCK SHARP & DOHME8PHARMACOPEIA DRUG DISCOVERY8GUZI TIMOTHY J4DWYER MICHAEL P2
Top patents by PatentIndex Score
68 records- 0194US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0294US6919341B2Imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2003·Granted Jul 19, 2005·65 cites·17 claims
- 0392US7605155B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Oct 20, 2009·28 cites·14 claims
- 0492US7601724B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Oct 13, 2009·22 cites·3 claims
- 0591US7119200B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2004·Granted Oct 10, 2006·45 cites·13 claims
- 0690US8586576B2Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsGUZI TIMOTHY J·Filed 2007·Granted Nov 19, 2013·15 cites·15 claims
- 0790US7196092B2N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2005·Granted Mar 27, 2007·15 cites·9 claims
- 0890US7196078B2Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORPOARTION·Filed 2005·Granted Mar 27, 2007·26 cites·29 claims
- 0988US8580782B2Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsGUZI TIMOTHY J·Filed 2007·Granted Nov 12, 2013·14 cites·20 claims
- 1088US8211854B2Methods for inhibiting protein kinasesGUZI TIMOTHY J·Filed 2010·Granted Jul 3, 2012·12 cites·2 claims
- 1188US7964646B23,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2006·Granted Jun 21, 2011·10 cites·47 claims
- 1288US7947720B23,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2009·Granted May 24, 2011·10 cites·4 claims
- 1388US7205308B2Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2005·Granted Apr 17, 2007·12 cites·14 claims
- 1488US7161003B1Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Jan 9, 2007·32 cites·31 claims
- 1587US7642266B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Jan 5, 2010·11 cites·21 claims
- 1687US7563798B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Jul 21, 2009·11 cites·3 claims
- 1786US7576085B2Imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2005·Granted Aug 18, 2009·10 cites·15 claims
- 1885US9254292B2Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseasesCOBURN CRAIG A·Filed 2011·Granted Feb 9, 2016·9 cites·9 claims
- 1985US8673924B2Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitorsGUZI TIMOTHY J·Filed 2007·Granted Mar 18, 2014·11 cites·25 claims
- 2085US8318735B22-aminothiazole-4-carboxylic amides as protein kinase inhibitorsSHIPPS JR GERALD W·Filed 2007·Granted Nov 27, 2012·10 cites·16 claims
- 2185US7776865B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Aug 17, 2010·9 cites·37 claims
- 2285US7645762B2Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Jan 12, 2010·8 cites·31 claims
- 2385US6903131B23,4-di-substituted maleimide compounds as CXC chemokine receptor antagonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Jun 7, 2005·28 cites·21 claims
- 2484US7468372B2Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Dec 23, 2008·7 cites·13 claims
- 2584US6878709B23,4-di-substituted pyridazinediones as CXC chemokine receptor antagonistsSCHERING CORP·Filed 2003·Granted Apr 12, 2005·20 cites·4 claims
- 2682US7078525B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Jul 18, 2006·15 cites·27 claims
- 2778US7452902B2Imidazopyridines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2005·Granted Nov 18, 2008·2 cites·3 claims
- 2878US6992080B2Imidazopyridines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2003·Granted Jan 31, 2006·7 cites·16 claims
- 2977US7309705B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Dec 18, 2007·2 cites·2 claims
- 3077US7084271B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Aug 1, 2006·9 cites·28 claims
- 3176US10287293B2Bicyclic heterocyclic compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted May 14, 2019·2 cites·22 claims
- 3276US8207221B2Crystalline polymorphs of a CXC-chemokine receptor ligandHU MENGWEI·Filed 2008·Granted Jun 26, 2012·2 cites·5 claims
- 3375US7186740B2Imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2003·Granted Mar 6, 2007·7 cites·18 claims
- 3474US10160762B26-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Dec 25, 2018·2 cites·17 claims
- 3572US7514442B2Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Apr 7, 2009·1 cites·12 claims
- 3672US7067661B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Jun 27, 2006·5 cites·21 claims
- 3770US10138255B2Piperazine derivatives as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Nov 27, 2018·1 cites·19 claims
- 3870US9840478B2Piperazine derivatives as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Dec 12, 2017·1 cites·13 claims
- 3967US7074924B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Jul 11, 2006·2 cites·28 claims
- 4063US8609676B24, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitorsCHELLIAH MARIAPPAN V·Filed 2010·Granted Dec 17, 2013·1 cites·12 claims
- 4159US7511049B2Pyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2007·Granted Mar 31, 2009·0 cites·10 claims
- 4257US7807683B2N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Oct 5, 2010·0 cites·11 claims
- 4355US7432265B2Imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2005·Granted Oct 7, 2008·0 cites·7 claims
- 4455US2007155751A1Novel imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2007·Application pending·0 cites
- 4553US7470695B2N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2006·Granted Dec 30, 2008·0 cites·12 claims
- 4653US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 4753US2007082900A1Methods for inhibiting protein kinasesSCHERING CORP·Filed 2006·Application pending·0 cites
- 4852US2007054925A1Novel pyrazolopyrimidines as cyclin dependent kinase inhibitorsPHARMACOPEIA INC·Filed 2006·Application pending·0 cites
- 4952US2004106794A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2002·Application pending·0 cites
- 5049US8642582B2Morpholinone compounds as factor IXa inhibitorsNISHIDA HIDEMITSU·Filed 2009·Granted Feb 4, 2014·0 cites·19 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael P. Dwyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →